This Article Full Text Full Text (PDF) All Versions of this Article: 200504-588OCv1 172/11/1434    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chen, Y.-Q. Articles by Wu, C. Search for Related Content PubMed PubMed Citation Articles by Chen, Y.-Q. Articles by Wu, C.

CD4⁺CD25⁺ Regulatory T Lymphocytes in Malignant Pleural Effusion

Institute of Respiratory Diseases, First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi, People's Republic of China

Correspondence and requests for reprints should be addressed to Dr. Huan-Zhong Shi, M.D., Ph.D., Institute of Respiratory Diseases, First Affiliated Hospital, Guangxi Medical University, Nanning 530021, Guangxi, P. R. China. E-mail: hzshi{at}vip.tom.com

Background: Active suppression by CD4⁺CD25⁺ regulatory T lymphocytes plays an important role in the downregulation of T-cell responses to foreign and self-antigens.

Objective: To analyze whether the CD4⁺CD25⁺ regulatory T lymphocytes exist and function normally in malignant pleural effusion.

Methods: The percentages of CD4⁺CD25⁺ T lymphocytes in pleural effusion and peripheral blood from patients with lung cancer with malignant effusion, pleural lavage and peripheral blood from patients with lung cancer without effusion, and peripheral blood from healthy control subjects were determined by flow cytometry. The expressions of forkhead transcription factor Foxp3 and cytotoxic lymphocyte-associated antigen-4 were also examined. CD4⁺CD25⁺ and CD4⁺CD25^– T cells from pleural effusion and peripheral blood were isolated, and were cultured to observe the effects of CD4⁺CD25⁺ cells on proliferation response of CD4⁺CD25^– T cells in vitro.

Main Results: There were increased numbers of CD4⁺CD25⁺ T cells in malignant pleural effusion from patients with lung cancer compared with pleural lavage from patients with lung cancer without pleural effusion, and that these cells have constitutive high-level expression of Foxp3 and cytotoxic lymphocyte-associated antigen-4. Furthermore, CD4⁺CD25⁺ T cells mediate potent inhibition of proliferation response of CD4⁺CD25^– T cells, and anticytotoxic lymphocyte-associated antigen-4 monoclonal antibody could reduce the inhibitory activity of CD4⁺CD25⁺ T cells.

Conclusions: The increased CD4⁺CD25⁺ T cells found in malignant pleural effusion express high levels of Foxp3 transcription factor and potently suppress the proliferation of CD4⁺CD25^– T cells, and cytotoxic lymphocyte-associated antigen-4 is involved in the suppressive activity of pleural CD4⁺CD25⁺ T cells.

Key Words: CD4⁺CD25⁺ T cells • lung cancer • pleural effusion • regulatory T lymphocyte

This article has been cited by other articles:

				X.-J. Qin, H.-Z. Shi, J.-M. Deng, Q.-L. Liang, J. Jiang, and Z.-J. Ye CCL22 Recruits CD4-positive CD25-positive Regulatory T Cells into Malignant Pleural Effusion Clin. Cancer Res., April 1, 2009; 15(7): 2231 - 2237. [Abstract] [Full Text] [PDF]

				J. R. Jett and Y. E. Miller Update in lung cancer 2005. Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 695 - 697. [Full Text] [PDF]